Research Output per year
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Rajat Bannerji
- Cancer Institute of New Jersey (CINJ), Hematologic Malignancies - ASSOC PROF-CLIN-DIV CHIEF
- Clinical Investigations and Precision Therapeutics Program, CINJ - ASSOCIATE MEMBER
Person
Kevin David
- Cancer Institute of New Jersey (CINJ), Hematologic Malignancies - ASST PROF-PROF PRAC
Person
Athena Kritharis
- Cancer Institute of New Jersey (CINJ), Hematologic Malignancies - ASST PROF-PROF PRAC
Person
Research Output
Combinatorial ixazomib and belinostat therapy induces NFE2L2-dependent apoptosis in Hodgkin and T-cell lymphoma
David, K. A. & Evens, A. M., Jan 1 2020, In : British Journal of Haematology. 188, 2, p. 295-308 14 p.Research output: Contribution to journal › Article
1
Scopus
citations
Current Treatment Options for Older Patients with Hodgkin Lymphoma
David, K. A. & Evens, A. M., May 1 2020, In : Current treatment options in oncology. 21, 5, 42.Research output: Contribution to journal › Review article
Interaction kinetics with transcriptomic and secretory responses of CD19-CAR natural killer-cell therapy in CD20 resistant non-hodgkin lymphoma
David, K. & Evens, A. M., May 1 2020, In : Leukemia. 34, 5, p. 1291-1304 14 p.Research output: Contribution to journal › Article
Press / Media
Combination immune therapy shows promise against Hodgkin lymphoma 6 Dec 2016
12/6/16
9 items of Media coverage
Press/Media: Press / Media
Appointments, Resignations, Deaths (1/15/2016)
1/10/16
1 item of Media coverage
Press/Media: Press / Media